ReviewJournal of cardiovascular translational research2026
Three-Dimensional Printing in Cardiovascular Medicine: Clinical Applications and Technological Advancements.
Review in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanical-medical convergence in heart failure: Artificial intelligence, finite-element modeling, and 3D printing for diagnosis and prognosis.Bioengineering & translational medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three-dimensional (3D) printing has rapidly evolved as a transformative technology in cardiovascular medicine, offering capabilities for anatomical modelling, surgical planning, and the development of biocompatible implants. This review synthesizes evidence from peer-reviewed studies to provide a comprehensive overview of 3D printing technologies, materials, and their clinical applications in cardiovascular fields, including myocardial tissue engineering, valve replacement, and vascular modelling. Emphasis is placed on patient-specific modelling, integration of bio-printing technologies, and recent clinical demonstrations of improved surgical precision and reduced implant rejection. Drawing on 28 primary sources, this review identifies current benefits and challenges of 3D printing in cardiovascular care, highlights emerging trends, and proposes future directions for research and clinical translation.
Indexed as
Identifiers
41639493What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.